KESHAVAN KODANDAPANI: Open Payments
NPI 1124167440 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $146 |
| Novo Nordisk Inc | 3 | $139 |
| Lilly USA, LLC | 1 | $16 |
Products named: CAPLYTA, Ozempic, Rybelsus, MOUNJARO.
Industry payments across NV — which companies pay providers there.
